XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash Flows from Operating Activities:    
Net increase (decrease) in net assets resulting from operations $ 12,514,752 $ 19,576,794
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Proceeds from sale and settlements of investments 87,901,740 39,760,986
Purchases, originations and participations (85,486,774) (49,334,640)
Investment increases due to payment-in-kind interest (1,015,546) (716,544)
Net amortization of premium (discount) on investments (365,717) (505,040)
Amortization of debt issuance cost 249,913 286,750
Amortization of deferred financing cost 339,587 198,530
Net realized (gains) losses from investments (7,137,352) 2,144,717
Net unrealized (gains) losses on investments (1,117,025) (17,079,448)
(Increase) decrease in operating assets:    
Interest receivable (744,169) (137,882)
Due from affiliate (41,964) (124,457)
Receivable for investments sold 3,940,175
Dividends receivable (54,226) 48,694
Paydown receivable 112,500
Other receivable (174,559) 30,157
Prepaid share repurchase 97,904 477,713
Other assets 422,435 577,239
Increase (decrease) in operating liabilities:    
Due to broker (16,550,000)
Payable for investments purchased (2,288,228) 5,118,912
Accounts payable and accrued expenses 722,418 (22,231)
Due to Affiliate 183,548
Administrator expenses payable 143,936 (74,911)
Interest and fees payable (170,341) 166,452
Deferred revenue (421,685) (70,301)
Other liabilities (105,653) (106,449)
Net cash provided by (used in) operating activities 7,393,169 (16,222,459)
Cash Flows from Financing Activities:    
Debt issuance 21,971,498 32,241,942
Paydowns on debt (21,178,988) (26,521,800)
Debt issuance costs paid (994) (9,752)
Deferred financing costs (289,505) (912,274)
Distributions paid to shareholders (2,645,925)
Repurchase of common shares (2,370,959) (467,538)
Net cash provided by (used in) financing activities (4,514,873) 4,330,578
Net increase (decrease) in cash and cash equivalents 2,878,296 (11,891,881)
Cash and cash equivalents, beginning of period 5,988,223 22,768,066
Cash and cash equivalents, end of period 8,866,519 10,876,185
Supplemental information:    
Interest paid during the period 4,365,399 2,608,928
Non-cash purchase of investments 45,900,000
Non-cash sale of investments $ 45,900,000